Tien-Li Lee
Chief Executive Officer at Aardvark Therapeutics Inc.
Sits on 2 boards. Last updated September 27, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 5 years
- Director since
- 2023
5 years of board service in total across 2 boards, counting each seat separately. Longest: Scilex Holding Company, 3 years.
Scilex Holding Company
Director
Aardvark Therapeutics Inc.
Director · Chief Executive Officer
Chief executive roles
Aardvark Therapeutics Inc.
· Chief Executive Officer
Since February 2025
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 11, 2025 | Aardvark Therapeutics Inc. | Open-market purchase | +7,000 | $14.49 | $101,430 |
| Oct 15, 2025 | Aardvark Therapeutics Inc. | Option exercise | +1,229 | $4.24 | $5,211 |
| Sep 15, 2025 | Aardvark Therapeutics Inc. | Open-market purchase | +6,500 | $9.51 | $61,815 |
| Sep 15, 2025 | Aardvark Therapeutics Inc. | Open-market purchase | +3,500 | $9.94 | $34,790 |
| Sep 12, 2025 | Aardvark Therapeutics Inc. | Open-market purchase | +5,000 | $8.50 | $42,500 |
| Sep 11, 2025 | Aardvark Therapeutics Inc. | Open-market purchase | +6,000 | $7.82 | $46,920 |
| Sep 10, 2025 | Aardvark Therapeutics Inc. | Open-market purchase | +9,000 | $7.91 | $71,190 |
| Aug 28, 2025 | Aardvark Therapeutics Inc. | Option exercise | +17,209 | $4.24 | $72,966 |
| Feb 14, 2025 | Aardvark Therapeutics Inc. | Derivative conversion | +41,303 | — | — |
| Feb 14, 2025 | Aardvark Therapeutics Inc. | Open-market purchase | +16,542 | $16.00 | $264,672 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.